Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for SIN3A_CHD1
Z-value: 1.95
Motif logo
Transcription factors associated with SIN3A_CHD1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SIN3A
|
ENSG00000169375.11 | SIN3 transcription regulator family member A |
|
CHD1
|
ENSG00000153922.6 | chromodomain helicase DNA binding protein 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SIN3A | hg19_v2_chr15_-_75743915_75743933, hg19_v2_chr15_-_75748115_75748126 | 0.55 | 1.8e-03 | Click! |
| CHD1 | hg19_v2_chr5_-_98262240_98262240 | -0.01 | 9.7e-01 | Click! |
Activity profile of SIN3A_CHD1 motif
Sorted Z-values of SIN3A_CHD1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr3_-_19988462 | 24.70 |
ENST00000344838.4
|
EFHB
|
EF-hand domain family, member B |
| chr4_-_7044657 | 14.65 |
ENST00000310085.4
|
CCDC96
|
coiled-coil domain containing 96 |
| chr16_-_66959429 | 14.39 |
ENST00000420652.1
ENST00000299759.6 |
RRAD
|
Ras-related associated with diabetes |
| chr13_+_35516390 | 14.11 |
ENST00000540320.1
ENST00000400445.3 ENST00000310336.4 |
NBEA
|
neurobeachin |
| chr19_-_7990991 | 13.90 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
| chr16_-_52580920 | 11.56 |
ENST00000219746.9
|
TOX3
|
TOX high mobility group box family member 3 |
| chr17_+_55333876 | 11.14 |
ENST00000284073.2
|
MSI2
|
musashi RNA-binding protein 2 |
| chr4_+_72052964 | 10.01 |
ENST00000264485.5
ENST00000425175.1 |
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
| chr11_-_75379612 | 8.62 |
ENST00000526740.1
|
MAP6
|
microtubule-associated protein 6 |
| chrX_+_16964794 | 8.46 |
ENST00000357277.3
|
REPS2
|
RALBP1 associated Eps domain containing 2 |
| chrX_+_16964985 | 8.39 |
ENST00000303843.7
|
REPS2
|
RALBP1 associated Eps domain containing 2 |
| chr16_+_67465016 | 7.36 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
| chr11_+_61276214 | 7.17 |
ENST00000378075.2
|
LRRC10B
|
leucine rich repeat containing 10B |
| chr13_-_37494365 | 7.13 |
ENST00000350148.5
|
SMAD9
|
SMAD family member 9 |
| chr5_-_180018540 | 6.94 |
ENST00000292641.3
|
SCGB3A1
|
secretoglobin, family 3A, member 1 |
| chr11_-_75380165 | 6.90 |
ENST00000304771.3
|
MAP6
|
microtubule-associated protein 6 |
| chr14_-_65438865 | 6.83 |
ENST00000267512.5
|
RAB15
|
RAB15, member RAS oncogene family |
| chr22_-_31741757 | 6.81 |
ENST00000215919.3
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1 |
| chr1_-_67390474 | 6.70 |
ENST00000371023.3
ENST00000371022.3 ENST00000371026.3 ENST00000431318.1 |
WDR78
|
WD repeat domain 78 |
| chr1_+_41827594 | 6.66 |
ENST00000372591.1
|
FOXO6
|
forkhead box O6 |
| chr7_-_131241361 | 6.59 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
PODXL
|
podocalyxin-like |
| chr6_+_107811162 | 6.36 |
ENST00000317357.5
|
SOBP
|
sine oculis binding protein homolog (Drosophila) |
| chr2_+_73612858 | 5.95 |
ENST00000409009.1
ENST00000264448.6 ENST00000377715.1 |
ALMS1
|
Alstrom syndrome 1 |
| chr5_+_42423872 | 5.93 |
ENST00000230882.4
ENST00000357703.3 |
GHR
|
growth hormone receptor |
| chr13_-_37494391 | 5.84 |
ENST00000379826.4
|
SMAD9
|
SMAD family member 9 |
| chrX_-_44202857 | 5.77 |
ENST00000420999.1
|
EFHC2
|
EF-hand domain (C-terminal) containing 2 |
| chr1_-_223537475 | 5.74 |
ENST00000344029.6
ENST00000494793.2 ENST00000366878.4 ENST00000366877.3 |
SUSD4
|
sushi domain containing 4 |
| chr6_-_111804393 | 5.72 |
ENST00000368802.3
ENST00000368805.1 |
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit |
| chr13_-_36705425 | 5.46 |
ENST00000255448.4
ENST00000360631.3 ENST00000379892.4 |
DCLK1
|
doublecortin-like kinase 1 |
| chr2_-_174828892 | 5.42 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
| chr9_-_124991124 | 5.39 |
ENST00000394319.4
ENST00000340587.3 |
LHX6
|
LIM homeobox 6 |
| chr3_-_18466787 | 5.26 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
| chr10_+_12391685 | 5.09 |
ENST00000378845.1
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID |
| chr4_-_16228083 | 5.03 |
ENST00000399920.3
|
TAPT1
|
transmembrane anterior posterior transformation 1 |
| chr6_-_29595779 | 5.02 |
ENST00000355973.3
ENST00000377012.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
| chr2_+_121103706 | 4.96 |
ENST00000295228.3
|
INHBB
|
inhibin, beta B |
| chr4_+_72053017 | 4.93 |
ENST00000351898.6
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
| chr10_-_28287968 | 4.85 |
ENST00000305242.5
|
ARMC4
|
armadillo repeat containing 4 |
| chr17_+_7788104 | 4.79 |
ENST00000380358.4
|
CHD3
|
chromodomain helicase DNA binding protein 3 |
| chr11_-_33891362 | 4.79 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
| chr11_+_45907177 | 4.75 |
ENST00000241014.2
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1 |
| chr20_+_51588873 | 4.72 |
ENST00000371497.5
|
TSHZ2
|
teashirt zinc finger homeobox 2 |
| chr20_+_56725952 | 4.61 |
ENST00000371168.3
|
C20orf85
|
chromosome 20 open reading frame 85 |
| chr5_+_139027877 | 4.56 |
ENST00000302517.3
|
CXXC5
|
CXXC finger protein 5 |
| chr18_-_24765248 | 4.55 |
ENST00000580774.1
ENST00000284224.8 |
CHST9
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
| chr7_-_158380371 | 4.52 |
ENST00000389418.4
ENST00000389416.4 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
| chr2_+_8822113 | 4.52 |
ENST00000396290.1
ENST00000331129.3 |
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
| chr10_+_12391481 | 4.48 |
ENST00000378847.3
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID |
| chr19_+_708910 | 4.41 |
ENST00000264560.7
|
PALM
|
paralemmin |
| chr19_+_709101 | 4.39 |
ENST00000338448.5
|
PALM
|
paralemmin |
| chr17_-_74137374 | 4.37 |
ENST00000322957.6
|
FOXJ1
|
forkhead box J1 |
| chr1_-_223537401 | 4.28 |
ENST00000343846.3
ENST00000454695.2 ENST00000484758.2 |
SUSD4
|
sushi domain containing 4 |
| chr9_+_34458771 | 4.28 |
ENST00000437363.1
ENST00000242317.4 |
DNAI1
|
dynein, axonemal, intermediate chain 1 |
| chr6_-_43478239 | 4.27 |
ENST00000372441.1
|
LRRC73
|
leucine rich repeat containing 73 |
| chr6_+_19837592 | 4.24 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
| chr5_+_32174483 | 4.19 |
ENST00000606994.1
|
CTD-2186M15.3
|
CTD-2186M15.3 |
| chr14_-_61190754 | 4.18 |
ENST00000216513.4
|
SIX4
|
SIX homeobox 4 |
| chr1_+_118148556 | 4.17 |
ENST00000369448.3
|
FAM46C
|
family with sequence similarity 46, member C |
| chr4_+_95679072 | 4.16 |
ENST00000515059.1
|
BMPR1B
|
bone morphogenetic protein receptor, type IB |
| chr9_-_120177216 | 4.15 |
ENST00000373996.3
ENST00000313400.4 ENST00000361477.3 |
ASTN2
|
astrotactin 2 |
| chr10_+_115803650 | 4.12 |
ENST00000369295.2
|
ADRB1
|
adrenoceptor beta 1 |
| chr10_-_13570533 | 4.11 |
ENST00000396900.2
ENST00000396898.2 |
BEND7
|
BEN domain containing 7 |
| chr2_-_230579185 | 4.08 |
ENST00000341772.4
|
DNER
|
delta/notch-like EGF repeat containing |
| chr9_-_120177342 | 4.05 |
ENST00000361209.2
|
ASTN2
|
astrotactin 2 |
| chr19_-_6110474 | 3.91 |
ENST00000587181.1
ENST00000587321.1 ENST00000586806.1 ENST00000589742.1 ENST00000592546.1 ENST00000303657.5 |
RFX2
|
regulatory factor X, 2 (influences HLA class II expression) |
| chr9_+_72435709 | 3.90 |
ENST00000377197.3
ENST00000527647.1 |
C9orf135
|
chromosome 9 open reading frame 135 |
| chr1_-_22469459 | 3.88 |
ENST00000290167.6
|
WNT4
|
wingless-type MMTV integration site family, member 4 |
| chr14_+_56585048 | 3.87 |
ENST00000267460.4
|
PELI2
|
pellino E3 ubiquitin protein ligase family member 2 |
| chr7_+_3340989 | 3.87 |
ENST00000404826.2
ENST00000389531.3 |
SDK1
|
sidekick cell adhesion molecule 1 |
| chr16_-_54320675 | 3.83 |
ENST00000329734.3
|
IRX3
|
iroquois homeobox 3 |
| chr11_+_94245617 | 3.78 |
ENST00000542198.1
|
RP11-867G2.2
|
long intergenic non-protein coding RNA 1171 |
| chr17_-_56065484 | 3.77 |
ENST00000581208.1
|
VEZF1
|
vascular endothelial zinc finger 1 |
| chr6_-_79787902 | 3.77 |
ENST00000275034.4
|
PHIP
|
pleckstrin homology domain interacting protein |
| chr19_+_41620335 | 3.76 |
ENST00000331105.2
|
CYP2F1
|
cytochrome P450, family 2, subfamily F, polypeptide 1 |
| chr19_+_13106383 | 3.73 |
ENST00000397661.2
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
| chr15_+_76352178 | 3.72 |
ENST00000388942.3
|
C15orf27
|
chromosome 15 open reading frame 27 |
| chr1_+_33722080 | 3.72 |
ENST00000483388.1
ENST00000539719.1 |
ZNF362
|
zinc finger protein 362 |
| chr19_+_4343524 | 3.70 |
ENST00000262966.8
ENST00000359935.4 ENST00000599840.1 |
MPND
|
MPN domain containing |
| chr9_+_140135665 | 3.69 |
ENST00000340384.4
|
TUBB4B
|
tubulin, beta 4B class IVb |
| chr14_+_67999999 | 3.69 |
ENST00000329153.5
|
PLEKHH1
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
| chr17_+_55334364 | 3.69 |
ENST00000322684.3
ENST00000579590.1 |
MSI2
|
musashi RNA-binding protein 2 |
| chr7_-_73184588 | 3.67 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr1_+_210406121 | 3.63 |
ENST00000367012.3
|
SERTAD4
|
SERTA domain containing 4 |
| chr14_-_65439132 | 3.63 |
ENST00000533601.2
|
RAB15
|
RAB15, member RAS oncogene family |
| chr19_+_4343691 | 3.60 |
ENST00000597036.1
|
MPND
|
MPN domain containing |
| chr9_+_96338647 | 3.59 |
ENST00000359246.4
|
PHF2
|
PHD finger protein 2 |
| chr22_-_37172111 | 3.57 |
ENST00000417951.2
ENST00000430701.1 ENST00000433985.2 |
IFT27
|
intraflagellar transport 27 homolog (Chlamydomonas) |
| chr6_+_157099036 | 3.54 |
ENST00000350026.5
ENST00000346085.5 ENST00000367148.1 ENST00000275248.4 |
ARID1B
|
AT rich interactive domain 1B (SWI1-like) |
| chr12_-_63328817 | 3.52 |
ENST00000228705.6
|
PPM1H
|
protein phosphatase, Mg2+/Mn2+ dependent, 1H |
| chr7_-_139876812 | 3.51 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr1_-_48937838 | 3.49 |
ENST00000371847.3
|
SPATA6
|
spermatogenesis associated 6 |
| chr17_+_14204389 | 3.47 |
ENST00000360954.2
|
HS3ST3B1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
| chr22_-_31503490 | 3.47 |
ENST00000400299.2
|
SELM
|
Selenoprotein M |
| chr16_-_66730583 | 3.46 |
ENST00000330687.4
ENST00000394106.2 ENST00000563952.1 |
CMTM4
|
CKLF-like MARVEL transmembrane domain containing 4 |
| chr11_-_93276582 | 3.46 |
ENST00000298966.2
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
| chr9_-_86432547 | 3.46 |
ENST00000376365.3
ENST00000376371.2 |
GKAP1
|
G kinase anchoring protein 1 |
| chr22_+_39853258 | 3.46 |
ENST00000341184.6
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
| chr6_-_109762344 | 3.45 |
ENST00000521072.2
ENST00000424445.2 ENST00000440797.2 |
PPIL6
|
peptidylprolyl isomerase (cyclophilin)-like 6 |
| chr18_-_30050395 | 3.41 |
ENST00000269209.6
ENST00000399218.4 |
GAREM
|
GRB2 associated, regulator of MAPK1 |
| chr22_-_37172191 | 3.41 |
ENST00000340630.5
|
IFT27
|
intraflagellar transport 27 homolog (Chlamydomonas) |
| chr1_+_205538105 | 3.38 |
ENST00000367147.4
ENST00000539267.1 |
MFSD4
|
major facilitator superfamily domain containing 4 |
| chr3_-_15901278 | 3.37 |
ENST00000399451.2
|
ANKRD28
|
ankyrin repeat domain 28 |
| chr6_+_36164487 | 3.36 |
ENST00000357641.6
|
BRPF3
|
bromodomain and PHD finger containing, 3 |
| chr15_-_45480153 | 3.33 |
ENST00000560471.1
ENST00000560540.1 |
SHF
|
Src homology 2 domain containing F |
| chr3_+_23986748 | 3.32 |
ENST00000312521.4
|
NR1D2
|
nuclear receptor subfamily 1, group D, member 2 |
| chr2_+_10183651 | 3.32 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
| chr11_-_106889157 | 3.31 |
ENST00000282249.2
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2 |
| chr10_+_120789223 | 3.29 |
ENST00000425699.1
|
NANOS1
|
nanos homolog 1 (Drosophila) |
| chr1_+_211433275 | 3.29 |
ENST00000367005.4
|
RCOR3
|
REST corepressor 3 |
| chr19_+_4343584 | 3.29 |
ENST00000596722.1
|
MPND
|
MPN domain containing |
| chr1_+_245133656 | 3.27 |
ENST00000366521.3
|
EFCAB2
|
EF-hand calcium binding domain 2 |
| chr22_+_29279552 | 3.25 |
ENST00000544604.2
|
ZNRF3
|
zinc and ring finger 3 |
| chr6_-_111804905 | 3.21 |
ENST00000358835.3
ENST00000435970.1 |
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit |
| chr17_+_8924837 | 3.14 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
| chr19_+_1285890 | 3.14 |
ENST00000344663.3
|
MUM1
|
melanoma associated antigen (mutated) 1 |
| chr17_+_36861735 | 3.12 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
| chr10_+_72164135 | 3.09 |
ENST00000373218.4
|
EIF4EBP2
|
eukaryotic translation initiation factor 4E binding protein 2 |
| chr18_-_45935663 | 3.09 |
ENST00000589194.1
ENST00000591279.1 ENST00000590855.1 ENST00000587107.1 ENST00000588970.1 ENST00000586525.1 ENST00000592387.1 ENST00000590800.1 |
ZBTB7C
|
zinc finger and BTB domain containing 7C |
| chr10_-_61513146 | 3.08 |
ENST00000430431.1
|
LINC00948
|
long intergenic non-protein coding RNA 948 |
| chr2_-_158732340 | 3.05 |
ENST00000539637.1
ENST00000413751.1 ENST00000434821.1 ENST00000424669.1 |
ACVR1
|
activin A receptor, type I |
| chr1_+_211432593 | 3.04 |
ENST00000367006.4
|
RCOR3
|
REST corepressor 3 |
| chr1_+_87794150 | 3.04 |
ENST00000370544.5
|
LMO4
|
LIM domain only 4 |
| chr7_-_99869799 | 3.01 |
ENST00000436886.2
|
GATS
|
GATS, stromal antigen 3 opposite strand |
| chr22_-_31742218 | 3.00 |
ENST00000266269.5
ENST00000405309.3 ENST00000351933.4 |
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1 |
| chr2_-_99757977 | 2.99 |
ENST00000355053.4
|
TSGA10
|
testis specific, 10 |
| chr5_+_127419449 | 2.97 |
ENST00000262461.2
ENST00000343225.4 |
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2 |
| chr10_+_70587279 | 2.97 |
ENST00000298596.6
ENST00000399169.4 ENST00000399165.4 ENST00000399162.2 |
STOX1
|
storkhead box 1 |
| chr9_-_126030817 | 2.96 |
ENST00000348403.5
ENST00000447404.2 ENST00000360998.3 |
STRBP
|
spermatid perinuclear RNA binding protein |
| chr1_+_114472222 | 2.94 |
ENST00000369558.1
ENST00000369561.4 |
HIPK1
|
homeodomain interacting protein kinase 1 |
| chr9_+_96338860 | 2.93 |
ENST00000375376.4
|
PHF2
|
PHD finger protein 2 |
| chr10_-_123357910 | 2.92 |
ENST00000336553.6
ENST00000457416.2 ENST00000360144.3 ENST00000369059.1 ENST00000356226.4 ENST00000351936.6 |
FGFR2
|
fibroblast growth factor receptor 2 |
| chr20_+_19193269 | 2.90 |
ENST00000328041.6
|
SLC24A3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
| chr2_+_176994408 | 2.89 |
ENST00000429017.1
ENST00000313173.4 ENST00000544999.1 |
HOXD8
|
homeobox D8 |
| chr19_-_821931 | 2.88 |
ENST00000359894.2
ENST00000520876.3 ENST00000519502.1 |
LPPR3
|
hsa-mir-3187 |
| chr9_+_129089088 | 2.88 |
ENST00000361171.3
ENST00000545391.1 |
MVB12B
|
multivesicular body subunit 12B |
| chr1_+_100818156 | 2.85 |
ENST00000336454.3
|
CDC14A
|
cell division cycle 14A |
| chr4_-_125633876 | 2.85 |
ENST00000504087.1
ENST00000515641.1 |
ANKRD50
|
ankyrin repeat domain 50 |
| chr6_-_90121938 | 2.84 |
ENST00000369415.4
|
RRAGD
|
Ras-related GTP binding D |
| chr3_-_9994021 | 2.84 |
ENST00000411976.2
ENST00000412055.1 |
PRRT3
|
proline-rich transmembrane protein 3 |
| chr17_+_68165657 | 2.83 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
| chr15_+_73344791 | 2.82 |
ENST00000261908.6
|
NEO1
|
neogenin 1 |
| chr1_-_223536679 | 2.81 |
ENST00000608996.1
|
SUSD4
|
sushi domain containing 4 |
| chr19_+_14544099 | 2.81 |
ENST00000242783.6
ENST00000586557.1 ENST00000590097.1 |
PKN1
|
protein kinase N1 |
| chr4_-_170192185 | 2.81 |
ENST00000284637.9
|
SH3RF1
|
SH3 domain containing ring finger 1 |
| chr10_+_69644404 | 2.79 |
ENST00000212015.6
|
SIRT1
|
sirtuin 1 |
| chr17_+_7155343 | 2.78 |
ENST00000573513.1
ENST00000354429.2 ENST00000574255.1 ENST00000396627.2 ENST00000356683.2 |
ELP5
|
elongator acetyltransferase complex subunit 5 |
| chr10_-_123357598 | 2.78 |
ENST00000358487.5
ENST00000369058.3 ENST00000369060.4 ENST00000359354.2 |
FGFR2
|
fibroblast growth factor receptor 2 |
| chr5_+_139028510 | 2.76 |
ENST00000502336.1
ENST00000520967.1 ENST00000511048.1 |
CXXC5
|
CXXC finger protein 5 |
| chr2_+_132286754 | 2.69 |
ENST00000434330.1
|
CCDC74A
|
coiled-coil domain containing 74A |
| chr4_-_25864581 | 2.69 |
ENST00000399878.3
|
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
| chr1_+_114472481 | 2.68 |
ENST00000369555.2
|
HIPK1
|
homeodomain interacting protein kinase 1 |
| chr11_-_2292182 | 2.67 |
ENST00000331289.4
|
ASCL2
|
achaete-scute family bHLH transcription factor 2 |
| chr2_-_99757876 | 2.64 |
ENST00000539964.1
ENST00000393482.3 |
TSGA10
|
testis specific, 10 |
| chr19_-_49149553 | 2.64 |
ENST00000084798.4
|
CA11
|
carbonic anhydrase XI |
| chr18_-_53255766 | 2.63 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
| chr4_+_30721968 | 2.62 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
| chr2_-_148778323 | 2.62 |
ENST00000440042.1
ENST00000535373.1 ENST00000540442.1 ENST00000536575.1 |
ORC4
|
origin recognition complex, subunit 4 |
| chr5_-_137368708 | 2.61 |
ENST00000033079.3
|
FAM13B
|
family with sequence similarity 13, member B |
| chr14_+_45431379 | 2.57 |
ENST00000361577.3
ENST00000361462.2 ENST00000382233.2 |
FAM179B
|
family with sequence similarity 179, member B |
| chr5_+_76506706 | 2.54 |
ENST00000340978.3
ENST00000346042.3 ENST00000264917.5 ENST00000342343.4 ENST00000333194.4 |
PDE8B
|
phosphodiesterase 8B |
| chr1_-_114301960 | 2.54 |
ENST00000369598.1
ENST00000369600.1 |
PHTF1
|
putative homeodomain transcription factor 1 |
| chr4_-_149365827 | 2.54 |
ENST00000344721.4
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
| chr14_+_96949319 | 2.53 |
ENST00000554706.1
|
AK7
|
adenylate kinase 7 |
| chr1_-_173991434 | 2.52 |
ENST00000367696.2
|
RC3H1
|
ring finger and CCCH-type domains 1 |
| chr14_-_93673353 | 2.51 |
ENST00000556566.1
ENST00000306954.4 |
C14orf142
|
chromosome 14 open reading frame 142 |
| chr8_-_140715294 | 2.51 |
ENST00000303015.1
ENST00000520439.1 |
KCNK9
|
potassium channel, subfamily K, member 9 |
| chr10_+_76585303 | 2.49 |
ENST00000372725.1
|
KAT6B
|
K(lysine) acetyltransferase 6B |
| chr6_+_17281573 | 2.49 |
ENST00000379052.5
|
RBM24
|
RNA binding motif protein 24 |
| chr20_+_36531499 | 2.49 |
ENST00000373458.3
ENST00000373461.4 ENST00000373459.4 |
VSTM2L
|
V-set and transmembrane domain containing 2 like |
| chr4_-_105416039 | 2.49 |
ENST00000394767.2
|
CXXC4
|
CXXC finger protein 4 |
| chr10_+_22610124 | 2.48 |
ENST00000376663.3
|
BMI1
|
BMI1 polycomb ring finger oncogene |
| chr4_-_147867025 | 2.47 |
ENST00000502319.1
ENST00000325106.4 ENST00000504425.1 |
TTC29
|
tetratricopeptide repeat domain 29 |
| chr8_-_80680078 | 2.47 |
ENST00000337919.5
ENST00000354724.3 |
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1 |
| chr1_+_217804661 | 2.45 |
ENST00000366933.4
|
SPATA17
|
spermatogenesis associated 17 |
| chr10_-_61513201 | 2.45 |
ENST00000414264.1
ENST00000594536.1 |
LINC00948
|
long intergenic non-protein coding RNA 948 |
| chr3_+_160473996 | 2.45 |
ENST00000498165.1
|
PPM1L
|
protein phosphatase, Mg2+/Mn2+ dependent, 1L |
| chr14_-_95786200 | 2.45 |
ENST00000298912.4
|
CLMN
|
calmin (calponin-like, transmembrane) |
| chr7_-_5821225 | 2.44 |
ENST00000416985.1
|
RNF216
|
ring finger protein 216 |
| chr14_-_67982146 | 2.44 |
ENST00000557779.1
ENST00000557006.1 |
TMEM229B
|
transmembrane protein 229B |
| chr20_+_2673383 | 2.44 |
ENST00000380648.4
ENST00000342725.5 |
EBF4
|
early B-cell factor 4 |
| chr2_+_97481974 | 2.44 |
ENST00000377060.3
ENST00000305510.3 |
CNNM3
|
cyclin M3 |
| chr10_-_105992059 | 2.43 |
ENST00000369720.1
ENST00000369719.1 ENST00000357060.3 ENST00000428666.1 ENST00000278064.2 |
WDR96
|
WD repeat domain 96 |
| chr4_-_147866960 | 2.43 |
ENST00000513335.1
|
TTC29
|
tetratricopeptide repeat domain 29 |
| chr10_+_35415851 | 2.42 |
ENST00000374726.3
|
CREM
|
cAMP responsive element modulator |
| chr17_+_62075703 | 2.42 |
ENST00000577953.1
ENST00000582540.1 ENST00000579184.1 ENST00000425164.3 ENST00000412177.1 ENST00000539996.1 ENST00000583891.1 ENST00000580752.1 |
C17orf72
|
chromosome 17 open reading frame 72 |
| chr2_-_48132814 | 2.41 |
ENST00000316377.4
ENST00000378314.3 |
FBXO11
|
F-box protein 11 |
| chr3_-_183979251 | 2.41 |
ENST00000296238.3
|
CAMK2N2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
| chr3_-_113415441 | 2.41 |
ENST00000491165.1
ENST00000316407.4 |
KIAA2018
|
KIAA2018 |
| chr1_-_114301755 | 2.39 |
ENST00000393357.2
ENST00000369596.2 ENST00000446739.1 |
PHTF1
|
putative homeodomain transcription factor 1 |
| chr1_-_109656439 | 2.38 |
ENST00000369949.4
|
C1orf194
|
chromosome 1 open reading frame 194 |
| chr3_+_58223228 | 2.36 |
ENST00000478253.1
ENST00000295962.4 |
ABHD6
|
abhydrolase domain containing 6 |
| chr1_-_114301503 | 2.36 |
ENST00000447664.2
|
PHTF1
|
putative homeodomain transcription factor 1 |
| chr11_-_118023490 | 2.35 |
ENST00000324727.4
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta subunit |
| chr22_+_39745930 | 2.34 |
ENST00000318801.4
ENST00000216155.7 ENST00000406293.3 ENST00000328933.5 |
SYNGR1
|
synaptogyrin 1 |
| chr9_-_92112953 | 2.32 |
ENST00000339861.4
ENST00000422704.2 ENST00000455551.2 |
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
| chr11_-_46142615 | 2.31 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
| chr20_+_9049682 | 2.30 |
ENST00000334005.3
ENST00000378473.3 |
PLCB4
|
phospholipase C, beta 4 |
| chr5_+_56111361 | 2.30 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
| chr8_+_37553261 | 2.29 |
ENST00000331569.4
|
ZNF703
|
zinc finger protein 703 |
| chr1_+_61547894 | 2.29 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
Network of associatons between targets according to the STRING database.
First level regulatory network of SIN3A_CHD1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.6 | 14.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 2.2 | 6.5 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 2.0 | 8.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 1.9 | 5.7 | GO:0035603 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 1.8 | 8.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.7 | 5.0 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 1.6 | 6.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.6 | 4.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.5 | 3.1 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
| 1.5 | 4.4 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 1.4 | 4.2 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 1.4 | 4.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 1.3 | 3.8 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.2 | 9.8 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.2 | 3.6 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 1.2 | 2.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.1 | 11.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 1.0 | 4.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.0 | 8.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.0 | 2.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
| 1.0 | 1.0 | GO:0061227 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 1.0 | 3.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 1.0 | 1.0 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 1.0 | 2.9 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 1.0 | 9.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 1.0 | 7.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 1.0 | 5.8 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
| 0.9 | 2.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.9 | 2.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.9 | 2.8 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.9 | 3.6 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.9 | 2.7 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.9 | 3.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.9 | 3.6 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 0.9 | 3.5 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
| 0.9 | 2.6 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.8 | 5.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.8 | 4.2 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.8 | 0.8 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) |
| 0.8 | 2.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.8 | 5.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.8 | 0.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.8 | 3.1 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.8 | 3.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.8 | 3.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.8 | 0.8 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
| 0.7 | 2.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.7 | 2.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.7 | 5.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.7 | 3.6 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.7 | 2.1 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.7 | 2.1 | GO:0070904 | L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.7 | 2.8 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.7 | 2.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.7 | 0.7 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.7 | 2.7 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.7 | 1.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.7 | 2.0 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.6 | 3.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.6 | 0.6 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.6 | 1.9 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.6 | 1.9 | GO:2000173 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.6 | 1.8 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.6 | 4.8 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.6 | 2.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.6 | 1.2 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 0.6 | 3.0 | GO:0019075 | virus maturation(GO:0019075) |
| 0.6 | 0.6 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.6 | 1.8 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.6 | 5.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.6 | 2.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.6 | 2.3 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.6 | 8.0 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.6 | 1.1 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.6 | 3.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.6 | 0.6 | GO:1902003 | beta-amyloid formation(GO:0034205) regulation of beta-amyloid formation(GO:1902003) positive regulation of beta-amyloid formation(GO:1902004) |
| 0.5 | 1.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.5 | 0.5 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.5 | 3.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.5 | 2.1 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.5 | 1.6 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.5 | 11.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.5 | 1.6 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.5 | 3.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.5 | 3.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.5 | 1.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.5 | 3.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.5 | 1.5 | GO:2000078 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.5 | 0.5 | GO:0002519 | natural killer cell tolerance induction(GO:0002519) |
| 0.5 | 1.5 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.5 | 2.0 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.5 | 8.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.5 | 1.5 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.5 | 2.0 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.5 | 1.0 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.5 | 1.4 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.5 | 1.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.5 | 5.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.5 | 0.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.5 | 1.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.5 | 0.5 | GO:0009411 | response to UV(GO:0009411) |
| 0.5 | 0.9 | GO:0051604 | protein maturation(GO:0051604) |
| 0.5 | 2.3 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.5 | 1.4 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.5 | 0.9 | GO:0009648 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.4 | 3.6 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.4 | 1.8 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.4 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.4 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.4 | 2.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.4 | 1.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.4 | 2.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.4 | 2.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.4 | 1.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.4 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.4 | 0.4 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.4 | 2.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.4 | 2.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.4 | 2.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.4 | 0.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.4 | 0.8 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.4 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.4 | 2.4 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.4 | 6.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.4 | 2.7 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.4 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.4 | 2.7 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.4 | 2.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.4 | 0.8 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.4 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.4 | 5.6 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.4 | 1.5 | GO:2000314 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.4 | 1.8 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.4 | 1.8 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
| 0.4 | 2.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 | 1.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.4 | 1.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.4 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 0.4 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.4 | 1.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.4 | 1.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.3 | 0.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.3 | 2.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.3 | 2.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 | 2.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 | 1.7 | GO:2001076 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.3 | 1.0 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.3 | 8.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.3 | 2.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.3 | 1.3 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.3 | 1.3 | GO:0032898 | neurotrophin production(GO:0032898) |
| 0.3 | 3.0 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.3 | 1.6 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.3 | 3.9 | GO:0007379 | segment specification(GO:0007379) |
| 0.3 | 1.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.3 | 0.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.3 | 2.6 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
| 0.3 | 4.1 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.3 | 1.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.3 | 0.9 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.3 | 0.9 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.3 | 1.3 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.3 | 2.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.3 | 2.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.3 | 1.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.3 | 1.2 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.3 | 0.9 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.3 | 1.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.3 | 0.9 | GO:0061508 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.3 | 2.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 | 1.2 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.3 | 3.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.3 | 1.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.3 | 0.6 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
| 0.3 | 7.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.3 | 0.9 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 0.3 | 0.9 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.3 | 0.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.3 | 3.2 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
| 0.3 | 1.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.3 | 1.7 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
| 0.3 | 0.8 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.3 | 0.6 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.3 | 1.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
| 0.3 | 2.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
| 0.3 | 2.2 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.3 | 0.8 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.3 | 1.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.3 | 0.8 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.3 | 1.3 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.3 | 2.9 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.3 | 0.5 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.3 | 1.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.3 | 1.9 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.3 | 0.8 | GO:0070839 | divalent metal ion export(GO:0070839) |
| 0.3 | 4.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.3 | 0.5 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.3 | 3.4 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.3 | 1.0 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.3 | 2.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.3 | 2.3 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.3 | 3.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.3 | 1.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.3 | 0.3 | GO:0072054 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.3 | 0.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 | 3.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.3 | 2.5 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.3 | 3.0 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.3 | 0.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.2 | 1.7 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.2 | 5.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.2 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
| 0.2 | 3.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.2 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 0.7 | GO:0035377 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.2 | 0.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 0.2 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 2.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.2 | 1.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.2 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.2 | 1.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.2 | 1.7 | GO:2000828 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.2 | 0.7 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.2 | 0.7 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 | 0.9 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 | 2.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 | 3.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 | 0.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.2 | 0.7 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.2 | 0.7 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.2 | 0.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.2 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.2 | 0.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 | 0.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 | 3.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 | 0.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 | 6.4 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.2 | 1.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.2 | 5.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 0.4 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
| 0.2 | 5.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 | 4.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 1.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.2 | 1.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.2 | 3.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.2 | 1.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 | 0.2 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 | 0.6 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.2 | 0.6 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.2 | 1.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.2 | 1.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.2 | 1.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.2 | 2.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.2 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.2 | 1.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 | 0.2 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.2 | 0.2 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.2 | 1.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
| 0.2 | 0.6 | GO:0010226 | response to lithium ion(GO:0010226) |
| 0.2 | 1.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.2 | 0.8 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 | 0.6 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.2 | 0.6 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.2 | 1.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 | 1.4 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.2 | 0.4 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 | 2.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 | 1.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.2 | 1.4 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.2 | 1.2 | GO:0061458 | reproductive system development(GO:0061458) |
| 0.2 | 7.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.2 | 2.3 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) |
| 0.2 | 0.4 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.2 | 6.2 | GO:0003341 | cilium movement(GO:0003341) |
| 0.2 | 0.2 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.2 | 1.5 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.2 | 1.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.2 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 | 0.6 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.2 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.2 | 0.6 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.2 | 0.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 | 6.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 0.6 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.2 | 0.6 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.2 | 4.9 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.2 | 0.6 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.2 | 0.9 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.2 | 0.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 1.1 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.2 | 1.3 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.2 | 0.5 | GO:0007595 | lactation(GO:0007595) |
| 0.2 | 0.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 0.5 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.2 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.2 | 0.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.2 | 1.3 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.2 | 2.5 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
| 0.2 | 0.4 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.2 | 1.4 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 | 0.7 | GO:0097009 | energy homeostasis(GO:0097009) |
| 0.2 | 0.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.2 | 3.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 | 0.7 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.2 | 1.4 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.2 | 1.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 | 2.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 1.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 | 0.9 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.2 | 0.7 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 | 1.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.2 | 1.6 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.2 | 3.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 2.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.2 | 0.7 | GO:0044782 | cilium organization(GO:0044782) |
| 0.2 | 4.5 | GO:0048864 | stem cell development(GO:0048864) |
| 0.2 | 0.3 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.2 | 0.7 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.2 | 0.5 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) positive regulation of lipid kinase activity(GO:0090218) |
| 0.2 | 0.9 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 2.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 | 1.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.2 | 2.5 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.2 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 | 1.8 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.2 | 1.0 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.2 | 0.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 | 1.0 | GO:0006983 | ER overload response(GO:0006983) |
| 0.2 | 0.3 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) |
| 0.2 | 1.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 | 6.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 | 1.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 2.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.2 | 0.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.2 | 1.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.2 | 0.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.2 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.2 | 0.8 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.2 | 0.8 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.2 | 0.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 | 1.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 0.6 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.2 | 0.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
| 0.2 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.2 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.2 | 0.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.2 | 1.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.2 | 0.9 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.2 | 0.5 | GO:0070781 | response to biotin(GO:0070781) |
| 0.2 | 1.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.2 | 0.5 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.2 | 1.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.2 | 0.5 | GO:0089709 | acyl carnitine transport(GO:0006844) histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) acyl carnitine transmembrane transport(GO:1902616) |
| 0.2 | 0.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 | 1.2 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
| 0.2 | 2.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.2 | 0.3 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 0.1 | 0.6 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.1 | 1.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 0.3 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 | 1.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 1.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.1 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.1 | 2.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.1 | GO:0003192 | mitral valve formation(GO:0003192) cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.1 | 0.4 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.1 | 0.4 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.1 | 0.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 | 3.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 | 1.7 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.1 | 0.1 | GO:0060038 | cardiac muscle cell proliferation(GO:0060038) |
| 0.1 | 0.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.1 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 1.3 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 | 8.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 0.3 | GO:0019230 | proprioception(GO:0019230) |
| 0.1 | 1.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 0.4 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.1 | 1.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.1 | 0.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 2.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 | 0.4 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 0.4 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 1.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 | 0.8 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.1 | 0.8 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 | 2.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 0.4 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
| 0.1 | 0.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.1 | 1.0 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 0.5 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.1 | 2.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 | 10.5 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.1 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.1 | 0.5 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.1 | 1.0 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 | 1.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 2.7 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.7 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.1 | 0.1 | GO:0070076 | histone lysine demethylation(GO:0070076) |
| 0.1 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 0.4 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.1 | 0.5 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.1 | 0.7 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.1 | 2.4 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.1 | 0.4 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 | 1.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.1 | 1.9 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.1 | 0.2 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |